Wanbury Limited - pharma in New Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L51900MH1988PLC048455 Incorporated 11 August 1988 ROC Mumbai HQ New Mumbai, Maharashtra, India
Active Listed - NSE: BE : WANBURY · BSE: 524212 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹650.27 Cr
▲ 8.47% YoY
Computed EBITDA · FY 2026
₹107.69 Cr
▲ 34.93% YoY
Net profit · FY 2026
₹66.13 Cr
▲ 116.62% YoY
Authorised capital
₹50 Cr
Registered with MCA
Paid-up capital
₹34.94 Cr
Issued & subscribed
Open charges
₹276 Cr
Satisfied ₹922.25 Cr
Company age
38 yrs
Est. 1988
Employees · EPFO
742
Latest available

About Wanbury Limited

Data last updated: 15 July 2026

Wanbury Limited is a public limited company based in New Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 11 August 1988, the company has been in operation for over 38 years.

Registered with ROC Mumbai under CIN L51900MH1988PLC048455. Listed on BSE: 524212 and NSE: BE : WANBURY.

Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹34.94 Cr. Formerly known as Pearl Organics Ltd and Pearl Organics Pvt Ltd. It is led by directors including Anupama Vaidya and Chandran Krishnamoorthy.

Last AGM: 18 September 2025. Financial statements filed for year ended 31 March 2025. Office: Sector 30, New Mumbai, Maharashtra.

As per NSE-filed standalone financials for FY 2026, the company reported a revenue of ₹650.27 Cr, a growth of 8.47% compared to the previous year. The net worth stands at ₹144.45 Cr (up 143.71% YoY). Total assets are valued at ₹517.67 Cr (up 25.07% YoY).

The company has a workforce of approximately 742 employees as per the latest available data.

The company is associated with 1 brand - Wanbury Limited. As per MCA filings, the company has open charges of ₹276 Cr and satisfied charges of ₹922.25 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wanbury.com.

Company Details of Wanbury Limited
CIN L51900MH1988PLC048455
Registration Number 048455
Incorporation Date 11 August 1988
ROC Mumbai
Listing Status Listed (BSE: 524212, NSE: BE : WANBURY)
Company Status Active
Date of Last AGM 18 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Bsel Tech Park 'B; Wing 10Th Floor Sector 30A Opp.Vashi Railway Station V, Ashi, New Mumbai, Maharashtra, India – 400703
  • Industry
    Pharma, API Manufacturers
Company report
Wanbury Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Wanbury Limited report

Financials, compliance, directors, charges, ownership and filings for Wanbury Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Wanbury Limited

Wanbury Limited has undergone 3 name changes throughout its history. The company was previously known as Pearl Organics Ltd, Pearl Organics Pvt Ltd, and Pearl Distributors Pvt Ltd. The current legal name is Wanbury Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Wanbury Limited Current
Pearl Organics Ltd Previous
Pearl Organics Pvt Ltd Previous
Pearl Distributors Pvt Ltd Previous

Associated Brands with Wanbury Limited

Wanbury Limited operates one associated brand: Wanbury Limited. These brands represent Wanbury Limited's diversified market presence and brand portfolio.

Brand Description Website
Anti-diabetic drugs and active pharmaceutical ingredients are manufactured. wanbury.com

Competitors & Alternatives of Wanbury Limited

Brands and companies operating in the same space as Wanbury Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.

Competitor Description Location Founded
Concord Biotech Concord Biotech APIs and enzymes are manufactured through fermentation by the CDMO. Ahmedabad, India, India 2000
BDR Pharmaceuticals Internationals BDR Pharmaceuticals Internationals APIs and finished products are developed and manufactured. Mumbai, India, India 2003
Almac Group Almac Group Integrated CDMO services for biopharma R&D and manufacturing are offered. Craigavon, United Kingdom, United Kingdom 2001
Indoco Remedies Indoco Remedies APIs manufacturing and formulation services are provided in therapeutic segments. Mumbai, India, India 1947
Pharmaceutics International Pharmaceutics International Pharmaceutical dosage forms are manufactured by this CDMO. Hunt Valley, United States, United States 1994
Aurobindo Pharma Aurobindo Pharma Generic biocatalytic solutions are provided for pharmaceutical applications. Hyderabad, India, India 1986
Seqens Seqens Contract manufacturing services for small molecules and peptides are provided. Ecully, France, France 2003
Asymchem Asymchem APIs and peptides are developed and manufactured by Asymchem. Morrisville, United States, United States 1995
Aptuit Aptuit Contract research and development services for small molecules are offered. Greenwich, United States, United States 2004
Continuus Pharma Continuus Pharma MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development Woburn, United States, United States 2012

Business Activity of Wanbury Limited

Wanbury Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Wanbury Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Wanbury Limited

Wanbury Limited is audited by M/s. Kapoor & Parekh Associates (ICAI peer reviewed, certificate valid till 2028-11-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s. Kapoor & Parekh Associates (ICAI peer reviewed, certificate valid till 2028-11-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Wanbury Limited

Wanbury Limited is currently managed by 6 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Anupama Vaidya Director 17 Mar 2022 4 Years 4 Months Current
Chandran Krishnamoorthy Whole-Time Director 01 Sep 2010 15 Years 10 Months Current
Manojkumar Khubchand Gursahani Director 08 Jan 2025 1 Years 6 Months Current
Pallavur Sankar Dass Vaidyanathan Director 08 Jan 2025 1 Years 6 Months Current
Mridul Sumanlal Mehta Director 12 Aug 2024 1 Years 11 Months Current
Mohan Kumar Rayana Whole-Time Director 21 Aug 2023 2 Years 11 Months Current

Financials of Wanbury Limited FY 2026 filings available

Wanbury Limited reported revenue of ₹650.27 Cr (up 8.47% YoY) for FY 2026.

Revenue · FY 2026
₹650.27 Cr ▲ 8.47%
Profit · FY 2026
₹66.13 Cr ▲ 116.62%
Computed EBITDA · FY 2026
₹107.69 Cr ▲ 34.93%
Revenue₹ Cr · Standalone0250500750FY 2020: ₹367 Cr367FY 2020FY 2021: ₹393 Cr · +6.8% YoY393+6.8%FY 2021FY 2022: ₹511 Cr · +30.2% YoY511+30.2%FY 2022FY 2023: ₹500 Cr · -2.3% YoY500-2.3%FY 2023FY 2024: ₹576 Cr · +15.2% YoY576+15.2%FY 2024FY 2025: ₹600 Cr · +4.1% YoY600+4.1%FY 2025FY 2026: ₹650 Cr · +8.5% YoY650+8.5%FY 2026
Net Profit₹ Cr · Standalone-50050100FY 2020: ₹0 Cr0.2FY 2020FY 2021: ₹13 Cr (loss) · -6145.9% YoY-12.6FY 2021FY 2022: ₹81 Cr · +746.3% YoY81.5+746.3%FY 2022FY 2023: ₹10 Cr (loss) · -112.8% YoY-10.4FY 2023FY 2024: ₹30 Cr · +392.4% YoY30.4+392.4%FY 2024FY 2025: ₹31 Cr · +0.4% YoY30.5+0.4%FY 2025FY 2026: ₹66 Cr · +116.6% YoY66.1+116.6%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200Q1'25: ₹131 Cr · -10.4% YoY131-10.4%Q1'25Q2'25: ₹161 Cr · +11.6% YoY161+11.6%Q2'25Q3'25: ₹133 Cr · -8.3% YoY133-8.3%Q3'25Q4'25: ₹172 Cr · +23.4% YoY172+23.4%Q4'25Q1'26: ₹163 Cr · +24.5% YoY163+24.5%Q1'26Q2'26: ₹160 Cr · -0.7% YoY160-0.7%Q2'26Q3'26: ₹162 Cr · +21.7% YoY162+21.7%Q3'26Q4'26: ₹165 Cr · -4.3% YoY165-4.3%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹650.27 Cr ₹599.51 Cr ₹575.65 Cr ₹499.65 Cr ₹511.19 Cr ₹392.52 Cr ₹367.45 Cr
Other Income ₹93.72 Lakh ₹3.49 Cr ₹2.99 Cr ₹91.32 Lakh ₹1.51 Cr ₹2.4 Cr ₹1.14 Cr
Total Income ₹651.21 Cr ₹603.01 Cr ₹578.64 Cr ₹500.56 Cr ₹512.69 Cr ₹394.92 Cr ₹368.59 Cr
Cost of Materials Consumed ₹272.9 Cr ₹277.88 Cr ₹289.22 Cr ₹257.48 Cr ₹304.93 Cr ₹213.7 Cr ₹146.42 Cr
Purchases of Stock-in-Trade ₹16.62 Cr ₹15.08 Cr ₹17.3 Cr ₹15.98 Cr ₹20.14 Cr ₹10.65 Cr ₹23.33 Cr
Changes in Inventories -₹13 Cr ₹1.51 Cr -₹3.89 Cr ₹29.13 Cr -₹24.79 Cr -₹7.2 Cr ₹5.99 Cr
Employee Benefit Expense ₹119.64 Cr ₹104.24 Cr ₹86.92 Cr ₹81 Cr ₹74.81 Cr ₹64.15 Cr ₹67.48 Cr
Finance Costs ₹29.98 Cr ₹36.95 Cr ₹29.18 Cr ₹21.39 Cr ₹20.61 Cr ₹23.07 Cr ₹32.87 Cr
Depreciation & Amortisation ₹14.31 Cr ₹13.31 Cr ₹13.03 Cr ₹12.38 Cr ₹11.45 Cr ₹9.75 Cr ₹9.68 Cr
Other Expenses ₹147.37 Cr ₹124.49 Cr ₹116.09 Cr ₹92.88 Cr ₹100.77 Cr ₹93.2 Cr ₹100.79 Cr
Total Expenses ₹587.8 Cr ₹573.46 Cr ₹547.86 Cr ₹510.25 Cr ₹507.93 Cr ₹407.33 Cr ₹386.56 Cr
Profit Before Exceptional Items & Tax ₹63.41 Cr ₹29.55 Cr ₹30.78 Cr -₹9.69 Cr ₹4.76 Cr -₹12.41 Cr -₹17.97 Cr
Exceptional Items -₹3.6 Cr ₹0 ₹0 -₹59.38 Lakh ₹76.37 Cr ₹0 ₹82.64 Cr
Profit Before Tax ₹59.8 Cr ₹29.55 Cr ₹30.78 Cr -₹10.29 Cr ₹81.13 Cr -₹12.41 Cr ₹64.67 Cr
Total Tax Expense -₹6.33 Cr -₹97.94 Lakh ₹38.1 Lakh ₹10.9 Lakh -₹34.62 Lakh ₹20 Lakh ₹64.46 Cr
Net Profit ₹66.13 Cr ₹30.53 Cr ₹30.4 Cr -₹10.4 Cr ₹81.47 Cr -₹12.61 Cr ₹20.85 Lakh
Other Comprehensive Income -₹54.96 Lakh -₹36.85 Lakh -₹70.94 Lakh ₹5.04 Lakh ₹1.12 Cr -₹44.11 Lakh -₹45.99 Lakh
Total Comprehensive Income ₹65.59 Cr ₹30.16 Cr ₹29.69 Cr -₹10.35 Cr ₹82.6 Cr -₹13.05 Cr -₹25.14 Lakh
EBITDA (computed) ₹107.69 Cr ₹79.81 Cr ₹72.99 Cr ₹24.08 Cr ₹36.82 Cr ₹20.42 Cr ₹24.59 Cr
Basic EPS ₹20.55 ₹9.32 ₹9.29 ₹-3.00 ₹1.59 ₹-5.04 ₹26.90
Diluted EPS ₹19.49 ₹8.98 ₹9.18 ₹-3.00 ₹1.58 ₹-5.04 ₹26.90
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹517.67 Cr ₹413.92 Cr ₹343.49 Cr ₹302.25 Cr
Non-current Assets ₹279.11 Cr ₹220.47 Cr ₹184.21 Cr ₹179.74 Cr
Current Assets ₹238.56 Cr ₹193.44 Cr ₹159.29 Cr ₹120.54 Cr
Property, Plant & Equipment ₹226.51 Cr ₹189.69 Cr ₹149.02 Cr ₹151.5 Cr
Inventories ₹50.63 Cr ₹37.68 Cr ₹36.02 Cr ₹21.99 Cr
Trade Receivables ₹143.28 Cr ₹114.16 Cr ₹89.44 Cr ₹67.98 Cr
Cash & Equivalents ₹1.61 Cr ₹4.06 Cr ₹3.4 Cr ₹1.46 Cr
Equity (Net Worth) ₹144.45 Cr ₹59.27 Cr ₹27.94 Cr -₹7.26 Cr
Equity Share Capital ₹34.94 Cr ₹32.77 Cr ₹32.75 Cr ₹32.71 Cr
Borrowings (Non-current) ₹147.15 Cr ₹160.29 Cr ₹82 Cr ₹0
Borrowings (Current) ₹68.3 Cr ₹12.94 Cr ₹27.95 Cr ₹64.14 Cr
Total Debt (computed) ₹215.45 Cr ₹173.23 Cr ₹109.95 Cr ₹64.14 Cr
Current Liabilities ₹201.04 Cr ₹174.61 Cr ₹214.11 Cr ₹293.19 Cr
Total Liabilities ₹373.22 Cr ₹354.65 Cr ₹315.55 Cr ₹309.5 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹31.53 Cr ₹26.1 Cr ₹4.02 Cr ₹19.8 Cr ₹37.56 Cr
Investing Cash Flow -₹56.4 Cr -₹51.17 Cr -₹16.63 Cr -₹8.84 Cr ₹58.65 Lakh
Financing Cash Flow ₹22.42 Cr ₹25.73 Cr ₹14.55 Cr -₹31.99 Cr -₹25.62 Cr
Capital Expenditure ₹59.06 Cr ₹49.03 Cr ₹0 ₹0 ₹0
Free Cash Flow (computed) -₹27.53 Cr -₹22.93 Cr ₹4.02 Cr ₹19.8 Cr ₹37.56 Cr
Dividends Paid ₹0 ₹0 ₹3.14 Cr ₹0 ₹0
Net Change in Cash -₹2.45 Cr ₹66.04 Lakh ₹1.94 Cr -₹21.03 Cr ₹12.53 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹164.58 Cr ₹162.45 Cr ₹160.06 Cr ₹163.18 Cr ₹172 Cr ₹133.45 Cr ₹161.19 Cr ₹131.11 Cr ₹139.41 Cr ₹145.5 Cr ₹144.46 Cr ₹146.29 Cr
Other Income ₹20.75 Lakh ₹17.83 Lakh ₹20.35 Lakh ₹34.79 Lakh ₹1.84 Cr ₹83.75 Lakh ₹1.63 Cr ₹94.46 Lakh ₹92.52 Lakh ₹69.25 Lakh ₹75.57 Lakh ₹61.66 Lakh
Total Income ₹164.79 Cr ₹162.63 Cr ₹160.26 Cr ₹163.53 Cr ₹173.84 Cr ₹134.29 Cr ₹162.82 Cr ₹132.05 Cr ₹140.33 Cr ₹146.19 Cr ₹145.22 Cr ₹146.9 Cr
Cost of Materials Consumed ₹62.95 Cr ₹66.51 Cr ₹70.66 Cr ₹72.78 Cr ₹75.95 Cr ₹60.91 Cr ₹76.82 Cr ₹64.2 Cr ₹66.87 Cr ₹63.85 Cr ₹75.75 Cr ₹82.75 Cr
Purchases of Stock-in-Trade ₹2.82 Cr ₹6.06 Cr ₹4.64 Cr ₹3.1 Cr ₹3.89 Cr ₹4.71 Cr ₹3.2 Cr ₹3.28 Cr ₹3.98 Cr ₹6.51 Cr ₹3.65 Cr ₹3.17 Cr
Changes in Inventories -₹46.37 Lakh -₹3.77 Cr -₹8.24 Cr -₹53.58 Lakh ₹4.48 Cr -₹3.75 Cr ₹2 Cr -₹1.22 Cr -₹42.22 Lakh ₹46.69 Lakh -₹3.05 Cr -₹88.92 Lakh
Employee Benefit Expense ₹29.68 Cr ₹31.84 Cr ₹29.43 Cr ₹28.69 Cr ₹26.42 Cr ₹26.31 Cr ₹26.35 Cr ₹25.15 Cr ₹20.14 Cr ₹24.63 Cr ₹21.07 Cr ₹21.08 Cr
Finance Costs ₹8.06 Cr ₹7.26 Cr ₹7.12 Cr ₹7.54 Cr ₹9.04 Cr ₹10.17 Cr ₹10.15 Cr ₹7.59 Cr ₹7.46 Cr ₹8.26 Cr ₹7.67 Cr ₹5.79 Cr
Depreciation & Amortisation ₹3.23 Cr ₹3.74 Cr ₹3.7 Cr ₹3.64 Cr ₹3.37 Cr ₹3.32 Cr ₹3.32 Cr ₹3.29 Cr ₹3.28 Cr ₹3.32 Cr ₹3.24 Cr ₹3.18 Cr
Other Expenses ₹39.74 Cr ₹35.13 Cr ₹37.79 Cr ₹34.71 Cr ₹31.63 Cr ₹31.32 Cr ₹32.81 Cr ₹28.73 Cr ₹30.68 Cr ₹28.89 Cr ₹29.69 Cr ₹26.83 Cr
Total Expenses ₹146.01 Cr ₹146.76 Cr ₹145.1 Cr ₹149.93 Cr ₹154.79 Cr ₹133 Cr ₹154.65 Cr ₹131.02 Cr ₹131.98 Cr ₹135.93 Cr ₹138.03 Cr ₹141.91 Cr
Profit Before Exceptional Items & Tax ₹18.77 Cr ₹15.87 Cr ₹15.16 Cr ₹13.61 Cr ₹19.05 Cr ₹1.29 Cr ₹8.17 Cr ₹1.04 Cr ₹8.35 Cr ₹10.26 Cr ₹7.19 Cr ₹4.99 Cr
Exceptional Items -₹3.6 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹15.17 Cr ₹15.87 Cr ₹15.16 Cr ₹13.61 Cr ₹19.05 Cr ₹1.29 Cr ₹8.17 Cr ₹1.04 Cr ₹8.35 Cr ₹10.26 Cr ₹7.19 Cr ₹4.99 Cr
Total Tax Expense -₹6.53 Cr ₹10.61 Lakh -₹1.93 Lakh ₹11.53 Lakh -₹1.2 Cr ₹7.44 Lakh ₹14.86 Lakh ₹0 ₹27.21 Lakh -₹1.72 Lakh -₹17.64 Lakh ₹30.24 Lakh
Net Profit ₹21.7 Cr ₹15.76 Cr ₹15.18 Cr ₹13.49 Cr ₹20.26 Cr ₹1.22 Cr ₹8.02 Cr ₹1.04 Cr ₹8.08 Cr ₹10.27 Cr ₹7.36 Cr ₹4.69 Cr
Other Comprehensive Income -₹17.32 Lakh -₹19.78 Lakh ₹3.61 Lakh -₹21.47 Lakh ₹4.66 Lakh -₹13.83 Lakh -₹42,000 -₹27.26 Lakh -₹46.92 Lakh ₹3.78 Lakh ₹38.89 Lakh -₹66.69 Lakh
Total Comprehensive Income ₹21.53 Cr ₹15.56 Cr ₹15.22 Cr ₹13.28 Cr ₹20.3 Cr ₹1.08 Cr ₹8.01 Cr ₹76.48 Lakh ₹7.61 Cr ₹10.31 Cr ₹7.75 Cr ₹4.02 Cr
EBITDA (computed) ₹30.06 Cr ₹26.86 Cr ₹25.98 Cr ₹24.79 Cr ₹31.47 Cr ₹14.78 Cr ₹21.64 Cr ₹11.92 Cr ₹19.09 Cr ₹21.84 Cr ₹18.1 Cr ₹13.96 Cr
Basic EPS ₹7.33 ₹4.52 ₹4.58 ₹4.12 ₹6.18 ₹0.38 ₹2.44 ₹0.32 ₹2.47 ₹3.14 ₹2.25 ₹1.43
Diluted EPS ₹6.34 ₹4.51 ₹4.58 ₹3.95 ₹5.98 ₹0.35 ₹2.44 ₹0.31 ₹2.37 ₹3.14 ₹2.25 ₹1.43
Latest 12 quarters shown of 25 on record.
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹599.51 Cr ₹575.65 Cr ₹499.65 Cr ₹511.19 Cr ₹392.52 Cr ₹367.45 Cr
Other Income ₹3.49 Cr ₹2.99 Cr ₹91.32 Lakh ₹1.51 Cr ₹2.4 Cr ₹1.14 Cr
Total Income ₹603.01 Cr ₹578.64 Cr ₹500.56 Cr ₹512.69 Cr ₹394.92 Cr ₹368.59 Cr
Cost of Materials Consumed ₹277.88 Cr ₹289.22 Cr ₹257.48 Cr ₹304.93 Cr ₹213.7 Cr ₹146.42 Cr
Purchases of Stock-in-Trade ₹15.08 Cr ₹17.3 Cr ₹15.98 Cr ₹20.14 Cr ₹10.65 Cr ₹23.33 Cr
Changes in Inventories ₹1.51 Cr -₹3.89 Cr ₹29.13 Cr -₹24.79 Cr -₹7.2 Cr ₹5.99 Cr
Employee Benefit Expense ₹104.24 Cr ₹86.92 Cr ₹81 Cr ₹74.81 Cr ₹64.15 Cr ₹67.48 Cr
Finance Costs ₹36.95 Cr ₹29.18 Cr ₹21.39 Cr ₹20.61 Cr ₹23.07 Cr ₹32.87 Cr
Depreciation & Amortisation ₹13.31 Cr ₹13.03 Cr ₹12.38 Cr ₹11.45 Cr ₹9.75 Cr ₹9.68 Cr
Other Expenses ₹124.49 Cr ₹116.09 Cr ₹92.88 Cr ₹100.77 Cr ₹93.2 Cr ₹100.79 Cr
Total Expenses ₹573.46 Cr ₹547.86 Cr ₹510.25 Cr ₹507.93 Cr ₹407.33 Cr ₹386.56 Cr
Profit Before Exceptional Items & Tax ₹29.55 Cr ₹30.78 Cr -₹9.69 Cr ₹4.76 Cr -₹12.41 Cr -₹17.97 Cr
Exceptional Items ₹0 ₹25.56 Cr -₹59.38 Lakh ₹76.37 Cr ₹0 ₹82.64 Cr
Profit Before Tax ₹29.55 Cr ₹56.34 Cr -₹10.29 Cr ₹81.13 Cr -₹12.41 Cr ₹64.67 Cr
Total Tax Expense -₹97.94 Lakh ₹38.1 Lakh ₹10.9 Lakh -₹34.62 Lakh ₹20 Lakh ₹20.87 Lakh
Net Profit ₹30.53 Cr ₹55.96 Cr -₹10.4 Cr ₹81.47 Cr -₹12.61 Cr ₹64.46 Cr
  attributable to Owners - ₹0 - ₹0 - ₹0
  attributable to NCI - ₹0 - ₹0 - ₹0
Other Comprehensive Income -₹36.85 Lakh -₹70.91 Lakh ₹10.09 Lakh ₹1.1 Cr -₹40.78 Lakh -₹39.33 Lakh
Total Comprehensive Income ₹30.16 Cr ₹55.25 Cr -₹10.29 Cr ₹82.58 Cr -₹13.01 Cr ₹64.07 Cr
EBITDA (computed) ₹79.81 Cr ₹72.99 Cr ₹24.09 Cr ₹36.82 Cr ₹20.42 Cr ₹24.58 Cr
Basic EPS ₹9.32 ₹9.29 ₹-3.00 ₹1.59 ₹-5.04 ₹26.90
Diluted EPS ₹8.98 ₹9.18 ₹-3.00 ₹1.58 ₹-5.04 ₹26.90
Metrics FY 2025 FY 2024 FY 2023
Total Assets ₹413.92 Cr ₹343.49 Cr ₹303.87 Cr
Non-current Assets ₹220.47 Cr ₹184.21 Cr ₹179.74 Cr
Current Assets ₹193.44 Cr ₹159.29 Cr ₹122.16 Cr
Property, Plant & Equipment ₹189.69 Cr ₹149.02 Cr ₹151.5 Cr
Inventories ₹37.68 Cr ₹36.02 Cr ₹21.99 Cr
Trade Receivables ₹114.16 Cr ₹89.44 Cr ₹67.98 Cr
Cash & Equivalents ₹4.06 Cr ₹3.4 Cr ₹1.49 Cr
Equity (Net Worth) ₹59.27 Cr ₹27.94 Cr -₹32.82 Cr
Equity Share Capital ₹32.77 Cr ₹32.75 Cr ₹32.71 Cr
Borrowings (Non-current) ₹160.29 Cr ₹82 Cr ₹0
Borrowings (Current) ₹12.94 Cr ₹27.95 Cr ₹64.14 Cr
Total Debt (computed) ₹173.23 Cr ₹109.95 Cr ₹64.14 Cr
Current Liabilities ₹174.61 Cr ₹214.11 Cr ₹320.37 Cr
Total Liabilities ₹354.65 Cr ₹315.55 Cr ₹336.69 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹26.1 Cr ₹3.98 Cr ₹19.8 Cr ₹37.56 Cr
Investing Cash Flow -₹51.17 Cr -₹16.63 Cr -₹8.84 Cr ₹58.65 Lakh
Financing Cash Flow ₹25.73 Cr ₹14.55 Cr -₹31.99 Cr -₹25.62 Cr
Capital Expenditure ₹49.03 Cr ₹17.42 Cr ₹0 ₹0
Free Cash Flow (computed) -₹22.93 Cr -₹13.45 Cr ₹19.8 Cr ₹37.56 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹66.04 Lakh ₹1.91 Cr -₹21.03 Cr ₹12.53 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24 Q4 FY23 Q3 FY23 Q2 FY23
Revenue from Operations ₹163.18 Cr ₹172 Cr ₹133.45 Cr ₹161.19 Cr ₹131.11 Cr ₹139.41 Cr ₹145.5 Cr ₹144.46 Cr ₹146.29 Cr ₹132.98 Cr ₹125.78 Cr ₹123.96 Cr
Other Income ₹34.79 Lakh ₹1.84 Cr ₹83.75 Lakh ₹1.63 Cr ₹94.46 Lakh ₹92.52 Lakh ₹69.24 Lakh ₹75.57 Lakh ₹61.66 Lakh -₹2.06 Cr ₹25.91 Lakh ₹78.04 Lakh
Total Income ₹163.53 Cr ₹173.84 Cr ₹134.29 Cr ₹162.82 Cr ₹132.05 Cr ₹140.33 Cr ₹146.19 Cr ₹145.22 Cr ₹146.9 Cr ₹130.91 Cr ₹126.04 Cr ₹124.74 Cr
Cost of Materials Consumed ₹72.78 Cr ₹75.95 Cr ₹60.91 Cr ₹76.82 Cr ₹64.2 Cr ₹66.87 Cr ₹63.85 Cr ₹75.75 Cr ₹82.75 Cr ₹64.45 Cr ₹65.76 Cr ₹64.4 Cr
Purchases of Stock-in-Trade ₹3.1 Cr ₹3.89 Cr ₹4.71 Cr ₹3.2 Cr ₹3.28 Cr ₹3.98 Cr ₹6.51 Cr ₹3.65 Cr ₹3.17 Cr ₹2.22 Cr ₹6.77 Cr ₹3.83 Cr
Changes in Inventories -₹53.58 Lakh ₹4.48 Cr -₹3.75 Cr ₹2 Cr -₹1.22 Cr -₹42.22 Lakh ₹46.7 Lakh -₹3.05 Cr -₹88.92 Lakh ₹7.63 Cr ₹3.84 Cr ₹7.86 Cr
Employee Benefit Expense ₹28.69 Cr ₹26.42 Cr ₹26.31 Cr ₹26.35 Cr ₹25.15 Cr ₹20.14 Cr ₹24.63 Cr ₹21.07 Cr ₹21.08 Cr ₹20.7 Cr ₹19.17 Cr ₹19.62 Cr
Finance Costs ₹7.54 Cr ₹9.04 Cr ₹10.17 Cr ₹10.15 Cr ₹7.59 Cr ₹7.46 Cr ₹8.26 Cr ₹7.67 Cr ₹5.79 Cr ₹7.51 Cr ₹6.63 Cr ₹3.94 Cr
Depreciation & Amortisation ₹3.64 Cr ₹3.37 Cr ₹3.32 Cr ₹3.32 Cr ₹3.29 Cr ₹3.28 Cr ₹3.32 Cr ₹3.24 Cr ₹3.18 Cr ₹3.07 Cr ₹3.13 Cr ₹3.15 Cr
Other Expenses ₹34.71 Cr ₹31.63 Cr ₹31.32 Cr ₹32.81 Cr ₹28.73 Cr ₹30.68 Cr ₹28.89 Cr ₹29.69 Cr ₹26.83 Cr ₹23.82 Cr ₹23.78 Cr ₹22.65 Cr
Total Expenses ₹149.93 Cr ₹154.79 Cr ₹133 Cr ₹154.65 Cr ₹131.02 Cr ₹131.98 Cr ₹135.93 Cr ₹138.03 Cr ₹141.91 Cr ₹129.4 Cr ₹129.08 Cr ₹125.45 Cr
Profit Before Exceptional Items & Tax ₹13.61 Cr ₹19.05 Cr ₹1.29 Cr ₹8.17 Cr ₹1.04 Cr ₹8.35 Cr ₹10.26 Cr ₹7.19 Cr ₹4.99 Cr ₹1.51 Cr -₹3.04 Cr -₹71 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹25.56 Cr ₹0 ₹0 ₹0 -₹59.38 Lakh ₹0 ₹0
Profit Before Tax ₹13.61 Cr ₹19.05 Cr ₹1.29 Cr ₹8.17 Cr ₹1.04 Cr ₹33.91 Cr ₹10.26 Cr ₹7.19 Cr ₹4.99 Cr ₹92.04 Lakh -₹3.04 Cr -₹71 Lakh
Total Tax Expense ₹11.53 Lakh -₹1.2 Cr ₹7.44 Lakh ₹14.86 Lakh ₹0 ₹27.21 Lakh -₹1.72 Lakh -₹17.64 Lakh ₹30.24 Lakh -₹9.52 Lakh ₹23.21 Lakh ₹17.98 Lakh
Net Profit ₹13.49 Cr ₹20.26 Cr ₹1.22 Cr ₹8.02 Cr ₹1.04 Cr ₹33.63 Cr ₹10.27 Cr ₹7.36 Cr ₹4.69 Cr ₹1.02 Cr -₹3.28 Cr -₹88.98 Lakh
  attributable to Owners ₹0 - ₹0 ₹0 ₹0 ₹0 - - - - - -
  attributable to NCI ₹0 - ₹0 ₹0 ₹0 ₹0 - - - - - -
Other Comprehensive Income -₹21.47 Lakh ₹4.66 Lakh -₹13.83 Lakh -₹15.28 Lakh -₹27.26 Lakh -₹52.51 Lakh ₹9.41 Lakh ₹37.17 Lakh -₹65.61 Lakh ₹26.86 Lakh -₹16.24 Lakh -₹38.1 Lakh
Total Comprehensive Income ₹13.28 Cr ₹20.3 Cr ₹1.08 Cr ₹7.87 Cr ₹76.48 Lakh ₹33.11 Cr ₹10.37 Cr ₹7.73 Cr ₹4.03 Cr ₹1.28 Cr -₹3.44 Cr -₹1.27 Cr
EBITDA (computed) ₹24.79 Cr ₹31.47 Cr ₹14.78 Cr ₹21.64 Cr ₹11.92 Cr ₹19.09 Cr ₹21.84 Cr ₹18.1 Cr ₹13.96 Cr ₹12.1 Cr ₹6.72 Cr ₹6.38 Cr
Basic EPS ₹4.12 ₹6.18 ₹0.38 ₹2.44 ₹0.32 ₹2.47 ₹3.13 ₹2.25 ₹1.43 ₹0.49 ₹-1.00 ₹-0.27
Diluted EPS ₹3.95 ₹5.98 ₹0.35 ₹2.34 ₹0.31 ₹2.37 ₹3.13 ₹2.25 ₹1.43 ₹0.49 ₹-1.00 ₹-0.27
Latest 12 quarters shown of 22 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Wanbury Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Wanbury Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 43.02%, foreign institutional investors hold 0.59%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 56.39% of Wanbury Limited. The company had 16,732 shareholders on record.

Promoters: 43.02%FII (Foreign Institutional): 0.59%Retail & Others: 56.39%
Mar 2026
QUARTER
43.02% Promoters
0.59% FII (Foreign Institutional)
56.39% Retail & Others
Promoter holding - history
Now 43.02% · Mar 2026High 56.11% · Feb 2017Low 39.63% · Jun 2025
38%43%48%53%58%Dec 2015Jun 2018Dec 2020Jun 2023Mar 2026Dec 2015: 48.97%Mar 2016: 48.97%Jun 2016: 48.97%Sep 2016: 48.97%Dec 2016: 48.97%Feb 2017: 56.11%Mar 2017: 56.11%Jun 2017: 56.11%Sep 2017: 56.11%Dec 2017: 56.11%Mar 2018: 54.93%Jun 2018: 54.93%Sep 2018: 54.93%Dec 2018: 54.93%Mar 2019: 54.93%Jun 2019: 54.93%Sep 2019: 54.93%Dec 2019: 54.93%Jan 2020: 52.18%Mar 2020: 52.13%Jun 2020: 52.13%Sep 2020: 52.09%Dec 2020: 52.09%Mar 2021: 52.09%Apr 2021: 39.93%Jun 2021: 39.90%Sep 2021: 39.90%Dec 2021: 39.89%Mar 2022: 39.89%Jun 2022: 39.85%Sep 2022: 39.85%Dec 2022: 39.84%Mar 2023: 39.84%Jun 2023: 39.84%Sep 2023: 39.80%Dec 2023: 39.79%Mar 2024: 39.79%Jun 2024: 39.79%Sep 2024: 39.77%Dec 2024: 39.76%Mar 2025: 39.76%Jun 2025: 39.63%Sep 2025: 43.09%Dec 2025: 43.07%Mar 2026: 43.02%56.11%39.63%43.02%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters43.02%43.07%43.09%39.63%39.76%39.76%
Public56.98%56.93%56.91%60.37%60.24%60.24%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters43.02%39.76%39.79%39.84%39.89%52.09%52.13%54.93%54.93%56.11%48.97%
Public56.98%60.24%60.21%60.16%60.11%47.91%47.87%45.07%45.07%43.89%51.03%
Promoter change (YoY, %pts)+3.26-0.03-0.05-0.05-12.20-0.04-2.80+0.00-1.18+7.14-

Board & Governance of Wanbury Limited

As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Wanbury Limited has 6 directors - 4 independent and 2 executive. The board is chaired by CHANDRAN KRISHNAMOORTHY.

DirectorPositionOn board sinceListed boards
CHANDRAN KRISHNAMOORTHY Executive Director · Chairperson 2010-09-01 1
MOHAN KUMAR RAYANA Executive Director 2023-08-21 1
ANUPAMA VAIDYA Non-Executive - Independent Director 2023-03-17 3
MRIDUL SUMANLAL MEHTA Non-Executive - Independent Director 2024-08-12 1
MANOJKUMAR KHUBCHAND GURSAHANI Non-Executive - Independent Director 2025-01-08 1
PALLAVUR SANKAR DASS VAIDYANATHAN Non-Executive - Independent Director 2025-01-08 1
Board Committees
CommitteeMembers
Audit Committee ANUPAMA VAIDYA, CHANDRAN KRISHNAMOORTHY, MRIDUL SUMANLAL MEHTA (Chairperson), MANOJKUMAR KHUBCHAND GURSAHANI, PALLAVUR SANKAR DASS VAIDYANATHAN
Nomination and remuneration committee ANUPAMA VAIDYA (Chairperson), MRIDUL SUMANLAL MEHTA, MANOJKUMAR KHUBCHAND GURSAHANI, PALLAVUR SANKAR DASS VAIDYANATHAN
Stakeholders Relationship Committee MRIDUL SUMANLAL MEHTA (Chairperson), ANUPAMA VAIDYA, CHANDRAN KRISHNAMOORTHY, MANOJKUMAR KHUBCHAND GURSAHANI, PALLAVUR SANKAR DASS VAIDYANATHAN

Charges & Borrowings of Wanbury Limited

Open charges
₹276 Cr
Satisfied charges
₹922.25 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹270.00 Cr
Others₹6.00 Cr
Latest charge details
DateLenderAmountStatus
24 Jun 2026 Sbicap Trustee Company Limited ₹205 Cr Open
23 Feb 2024 Sbicap Trustee Company Limited ₹65 Cr Open
22 Apr 2014 Others ₹6 Cr Open
27 Feb 2025 Others ₹200 Cr Satisfied
10 Jun 2024 Sbicap Trustee Company Limited ₹60 Cr Satisfied

Total charge records: 32 View all charges

Employees and EPFO Compliance at Wanbury Limited

Wanbury Limited has a workforce of 742 employees as of Apr 05, 2024.

Employee count
742
Active EPFO establishments
2
Employee growth
-4.26%
Premium access

Employee and EPFO history for Wanbury Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Wanbury Limited

Premium access

GST registrations and filing compliance for Wanbury Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Wanbury Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Wanbury Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Wanbury Limited

Premium access

MSME payment history for Wanbury Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Wanbury Limited

Premium access

Corporate group structure for Wanbury Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Wanbury Limited

Premium access

MCA filings and documents for Wanbury Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Wanbury Limited

Charges
09 Jul 2026
A charge registered on 27 Feb 2025 via Charge ID 101084774 with Others was fully satisfied on 09 Jul 2026.
Charges
24 Jun 2026
A charge with Sbicap Trustee Company Limited amounted to Rs. 205.00 Cr with Charge ID 101323851 was registered on 24 Jun 2026.
Charges
06 May 2026
A charge with Sbicap Trustee Company Limited of Rs. 65.00 Cr registered on 23 Feb 2024 with Charge ID 100877119 was modified on 06 May 2026.
Charges
02 Mar 2026
A charge with Others of Rs. 6.00 Cr registered on 22 Apr 2014 with Charge ID 10490144 was modified on 02 Mar 2026.
Charges
30 Sep 2025
A charge with Others of Rs. 200.00 Cr registered on 27 Feb 2025 with Charge ID 101084774 was modified on 30 Sep 2025.
Activity
18 Sep 2025
Wanbury Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records.

Frequently Asked Questions about Wanbury Limited

Wanbury Limited is an active public limited company in the pharma sector based in New Mumbai, Maharashtra, India. It was incorporated on 11 August 1988 (38+ years old) and is registered under CIN L51900MH1988PLC048455. Listed on BSE: 524212 and NSE: BE : WANBURY. The company has 742 employees.

Wanbury Limited reported revenue of ₹650.27 Cr for FY 2026 (up 8.47% YoY) based on standalone NSE filings.

The current directors of Wanbury Limited are:

The primary industry of Wanbury Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Wanbury Limited is listed on both BSE (code: 524212) and NSE (symbol: BE : WANBURY).

Wanbury Limited can be reached at the registered office: Bsel Tech Park B; Wing 10Th Floor Sector 30A Opp.Vashi Railway Station V, Ashi, New Mumbai, Maharashtra, India – 400703, or through the website wanbury.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available